Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a Large Cohort of US Veterans
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Alexander Matelski und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Viremia, Veterans, Sustained Virologic Response, Antiviral Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Chronic hepatitis C virus (HCV) infection affects >1% of the US population and a larger percentage of US veterans. Direct-acting antiviral (DAA) medications achieve viral cure, termed sustained virologic response (SVR), but repeat viremia after SVR is recognized. Prior work has been limited by electronic medical record data. We aim to better understand repeat viremia in the DAA era through detailed chart review.
Methods
We identified 1129 individuals from the Veterans Health Administration (VHA) who achieved SVR using DAA therapy but subsequently had detectable HCV viremia. A random subset of 110 was chart-reviewed and assigned to 1 of the following 4 categories using laboratory, diagnosis, and chart review data: definite reinfection (25.5%), probable reinfection (25.5%), false-positive (11.8%), and presumed late relapse (37.3%). We conducted between-group analysis of variance to identify demographic, behavioral, and laboratory features specific to each.
Results
In our medical record cohort (n = 1129), substance use and unstable housing were common, and median time to repeat viremia was 1.9 years. In our chart review cohort (n = 110), younger age (18–34 years) and substance use were more frequent in definite or probable reinfection. Presumed relapse had comparatively more hepatocellular carcinoma (HCC; 20%, P < .05), and more than half occurred prior to 1 year. The unique category of false-positive has not previously been reported.
Conclusions
This study deepens our understanding of HCV reinfection and relapse and highlights features including the HCV and opioid syndemic, contribution of laboratory error, possibility of a viral reservoir in HCC, and clinical engagement implications for those with ongoing risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
- Division of General Internal Medicine, Veterans Affairs Puget Sound Healthcare System, Seattle, Washington, USA.
- School of Public Health, Oregon Health & Science University-Portland State University, Portland, Oregon, USA.
- Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
- Veterans Affairs Puget Sound Healthcare System, Seattle, Washington, USA.
ORCID-Profile: Alexander Matelski, Cara D Varley, Elliott Lowy, Emily J Cartwright, Karine Rozenberg-Ben-Dror
Zitieren
APA
Matelski, A., Gregoire, B., Beste, L. A., Varley, C. D., Lowy, E., Cartwright, E. J., Morgan, T. R., Ross, D. B., Rozenberg-Ben-Dror, K., & Maier, M. M. (2025). Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a Large Cohort of US Veterans. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf008
Vancouver
Matelski A, Gregoire B, Beste LA, Varley CD, Lowy E, Cartwright EJ, et al. Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a Large Cohort of US Veterans. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf008
BibTeX
@article{Matelski2025,
author = {Matelski, Alexander and Gregoire, Bruce and Beste, Lauren A and Varley, Cara D and Lowy, Elliott and Cartwright, Emily J and Morgan, Timothy R and Ross, David B and Rozenberg-Ben-Dror, Karine and Maier, Marissa M},
title = {Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a Large Cohort of US Veterans},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf008}
}
EUVIMED